Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti–obesity-diabetes actions of (Pro3)GIP

✍ Scribed by P. L. McClean; V. A. Gault; N. Irwin; J. T. McCluskey; P. R. Flatt

• Book ID: 109044488
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 211 KB
• Volume: 10
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2007.00712.x